Products & ServicesEvent: September 7, 2026
Insight has launched ClinCraft, an AI-powered clinical trial protocol generation and optimisation platform designed to accelerate protocol development, improve trial design, and help organisations make more informed decisions earlier in the clinical development process.
Published
Signal category
Products & Services
Quote
“ClinCraft is designed to accelerate protocol development, improve trial design, and help organisations make more informed decisions earlier in the clinical development process.”
— Insight team
Company
Insight
Accelerating drug discovery with AI-driven clarity and regulatory insight
- Industry
- Hospitals and Health Care
- Location
- London, GB
- Company size
- 5 employees
Insight delivers AI-driven pharmaceutical intelligence, offering real-time data on compounds, clinical trials, disease profiles, targets, regulatory intelligence and company analysis to help researchers assess drug safety, effectiveness and development opportunities and accelerate informed decision-making in drug research and development.
Founded 2021